Aaron Falcione - Mar 31, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Aaron Falcione
Stock symbol
OGN
Transactions as of
Mar 31, 2024
Transactions value $
-$66,402
Form type
4
Date filed
4/3/2024, 06:41 PM
Previous filing
Apr 2, 2024
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +3.58K +16.4% $0.00 25.4K Mar 31, 2024 Direct
transaction OGN Common Stock Tax liability -$23K -1.23K -4.83% $18.80 24.2K Mar 31, 2024 Direct
transaction OGN Common Stock Options Exercise $0 +6.73K +27.85% $0.00 30.9K Mar 31, 2024 Direct
transaction OGN Common Stock Tax liability -$43.4K -2.31K -7.46% $18.80 28.6K Mar 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -3.58K -49.99% $0.00 3.58K Mar 31, 2024 Common Stock 3.58K Direct F1, F2
transaction OGN Restricted Stock Units Options Exercise $0 -6.73K -33.33% $0.00 13.5K Mar 31, 2024 Common Stock 6.73K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
F3 On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.